Gene · 3568
Papers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neuroplasticity and neuroimmune interactions with type 2 inflammation in asthma. | Eur Respir Rev | 2026 | 41638876 | PubTator, text mining | PubMed |
| Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA): Do We Need Immunosuppressives? | J Allergy Clin Immunol Pract | 2026 | 41616960 | PubTator, text mining | PubMed |
| Polygenic risk score for lower limb skeletal muscle mass and its interaction with protein and vitamin D intake in older adults. | Nutrition | 2026 | 41616609 | PubTator, text mining | PubMed |
| Precision Medicine for Asthma: Tailored to its Severity and Endotype/Phenotype. | Allergy Asthma Immunol Res | 2026 | 41592537 | PubTator, text mining | PubMed |
| Connecting the Airways: Current Trends in United Airway Diseases. | J Pers Med | 2026 | 41590514 | PubTator, text mining | PubMed |
| Clinical remission in patients with severe eosinophilic asthma treated with benralizumab over 24 months: Post hoc analysis of the ANANKE study. | World Allergy Organ J | 2026 | 41583079 | PubTator, text mining | PubMed |
| Central compartment atopic disease: Advances in pathogenesis and stratified treatment. | J Int Med Res | 2026 | 41575166 | PubTator, text mining | PubMed |
| Targeting Immunologic Pathways in Eosinophilic Granulomatosis With Polyangiitis: Translating Emerging Evidence Into Clinical Practice. | Allergy | 2026 | 41574554 | PubTator, text mining | PubMed |
| A Systematic Review of the Specific Role of Biological Therapies in Aspirin-Exacerbated Respiratory Disease. | J Investig Allergol Clin Immunol | 2026 | 41556270 | PubTator, text mining | PubMed |
| Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS Syndrome) Manifesting With Pseudolymphoma Multisystemic Organ Involvement. | Clin Case Rep | 2026 | 41550396 | PubTator, text mining | PubMed |
| The emerging role of anti-thymic stromal lymphopoietin monoclonal antibody (Tezepelumab) in comorbid and non-comorbid CRSwNP patients: a scoping review. | Braz J Otorhinolaryngol | 2026 | 41548510 | PubTator, text mining | PubMed |
| Efficacy of biologic agents in patients with comorbid asthma and chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis of randomised controlled trials. | Eur Respir Rev | 2026 | 41534885 | PubTator, text mining | PubMed |
| Fractional exhaled nitric oxide in monitoring biological treatment for severe asthma in adults: Clinical implications and future perspectives. | Respir Med | 2026 | 41534721 | PubTator, text mining | PubMed |
| Burden of severe asthma in Italy: Patients treated with versus eligible for monoclonal antibodies in a large real-world study. | J Int Med Res | 2026 | 41529921 | PubTator, text mining | PubMed |
| Real-world outcomes after anti-IL-5/anti-IL-5Rα treatment for hypereosinophilic syndrome: Systematic literature review. | J Allergy Clin Immunol Glob | 2026 | 41488420 | PubTator, text mining | PubMed |
| Eosinophils (EOS): the Greek dawn goddess of the same name. | J Leukoc Biol | 2026 | 41347958 | PubTator, text mining | PubMed |
| Adjunctive dual biologic therapy for persistent nasal symptoms in eosinophilic granulomatosis with polyangiitis (EGPA). | Am J Otolaryngol | 2026 | 41343954 | PubTator, text mining | PubMed |
| Long-term efficacy but rare sustained remission: individual-level 5-year stability in anti-IL5/Rα biologic therapy response for severe asthma. | Eur Respir J | 2026 | 41309267 | PubTator, text mining | PubMed |
| How to choose a biologic agent considering comorbidities of bronchial asthma. | Respir Investig | 2026 | 41297379 | PubTator, text mining | PubMed |
| Glucocorticoid Treatment in Severe Asthma. | Semin Respir Crit Care Med | 2026 | 41237810 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3568/papers?page=5